ABCB1 rs1128250: Understanding Your Genetic Variant
The rs1128250 variant is a common genetic change located within the ABCB1 gene. It is associated with potential variations in the expression and function of P-glycoprotein, a protein that helps transport substances across cell membranes.
What each genotype means
Typical P-glycoprotein expression
This genotype is often considered the reference state for this variant. Research into how this specific genetic pattern influences medication transport has yielded conflicting results, and the clinical relevance remains limited. Please discuss any concerns regarding your medication response or dosing with your clinician or pharmacist.
This is a common genotype found across diverse global populations.
Intermediate P-glycoprotein expression
As a carrier of both the C and T alleles, your genetic profile represents a mix of the two common forms of this variant. Studies have not consistently shown that this genotype leads to significant differences in how your body processes medications compared to other genotypes. Always consult your healthcare provider before making changes to your prescribed treatments.
This is a common genotype observed frequently in many ethnic groups.
Potential altered P-glycoprotein expression
Some research suggests that this genotype may be associated with variations in the stability or expression levels of the P-glycoprotein transporter, which helps move substances out of cells. However, scientific evidence linking this specific genotype to meaningful differences in drug efficacy or side effects is inconsistent and limited. Please discuss your medication regimen with your doctor or pharmacist to ensure your treatment is appropriate for you.
This genotype is present in a significant portion of the population, though frequencies vary by ancestry.
What is the rs1128250 Variant?
The rs1128250 variant is a single nucleotide polymorphism (SNP) found within the ABCB1 gene, which is located on chromosome 7. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is often studied in the context of pharmacogenomics, the field that examines how an individual's genetic makeup influences their response to drugs. Because this variant sits within a gene responsible for cellular transport, researchers investigate whether it alters the efficiency with which cells move molecules, including certain medications, into or out of the cell. It is important to note that while this variant is frequently identified in genomic studies, its functional impact can be subtle and may depend on other genetic and environmental factors.
The Role of the ABCB1 Gene
The ABCB1 gene provides instructions for making a protein called P-glycoprotein, also known as multidrug resistance protein 1 (MDR1). This protein acts as a transmembrane efflux pump, meaning it sits in the cell membrane and uses energy from ATP to push various substances out of the cell. P-glycoprotein is found in many tissues, including the lining of the intestines, the blood-brain barrier, and the liver. By pumping substances out of cells, it plays a critical role in protecting the body from toxins and regulating the absorption and distribution of many therapeutic drugs. When the expression or function of this pump is altered, it can theoretically change how much of a medication reaches its target site in the body, potentially affecting both the efficacy and the safety profile of those treatments.
Research and Evidence Strength
Research into rs1128250 has primarily focused on its association with drug pharmacokinetics. While some studies suggest that variants in the ABCB1 gene may influence the transport of substrates like certain anti-cancer drugs or anti-epileptic medications, the evidence strength for rs1128250 specifically remains limited. Scientific literature often shows mixed results, with some studies finding correlations between the variant and drug response, while others find no significant clinical difference. Because drug response is a complex trait influenced by many genes, diet, and other health conditions, it is difficult to isolate the effect of a single SNP. Consequently, this variant is not currently used as a definitive clinical tool for prescribing medications. Any questions regarding how your specific genetic profile might interact with a prescribed treatment should be discussed directly with your healthcare provider or a clinical pharmacist.
Population Frequency
The rs1128250 variant is considered a common polymorphism, meaning it is found at relatively high frequencies across many global populations. Genetic databases indicate that the distribution of the alleles can vary between different ancestral groups, which is a standard observation for many common SNPs. Because it is widespread, it is frequently included in large-scale genomic studies and pharmacogenetic research panels. However, the clinical relevance of this frequency is still being evaluated by the scientific community, as common variants often have smaller individual effects on health outcomes compared to rare, high-impact mutations.
Navigating Genetic Information
Understanding your genetic data can be empowering, but it is essential to interpret findings like rs1128250 with caution. Because the evidence linking this variant to specific clinical outcomes is limited, it should not be used to make independent medical decisions or to alter medication dosages. Genetic associations are statistical observations made across large groups of people and do not necessarily predict how an individual will respond to a specific drug. If you have received a report mentioning this variant, view it as a piece of information to discuss with your doctor. A clinician can integrate your genetic information with your medical history, current medications, and other clinical factors to provide personalized care. Always consult a professional before making any changes to your health regimen.
How common is this variant?
The rs1128250 variant is a common polymorphism observed across diverse human populations, with allele frequencies varying by ancestry.
Frequently asked questions
Does having the rs1128250 variant mean I will have drug resistance?
No, having this variant does not guarantee drug resistance. While the ABCB1 gene is involved in drug transport, many other factors, including your overall genetic profile and environment, determine how you respond to medication.
Should I change my medication based on this result?
You should never change your medication based on a genetic test result without consulting your doctor. Only a healthcare professional can determine if a change is appropriate based on your full clinical picture.
Is rs1128250 the same as the 3435C>T variant?
No, rs1128250 is a distinct variant from the well-studied 3435C>T (rs1045642) polymorphism. Both are located in the ABCB1 gene, but they represent different positions in the DNA sequence.
Where can I find more information about ABCB1 pharmacogenetics?
You can search resources like PharmGKB or PubMed for peer-reviewed research on ABCB1. These databases provide summaries of how specific genetic variants may influence drug metabolism and transport.
Sources & further reading
Educational information only, last refreshed 9/15/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1128250?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ABCB1
Coding variant in ABCB1 (MDR1) altering P-glycoprotein transport efficiency and modulating multidrug resistance and toxicity profiles.
Nonsynonymous variant (Ala893Ser/Thr) in ABCB1/MDR1 altering P-glycoprotein transporter kinetics and plasma concentrations of drugs such as digoxin, fexofenadine, and tacrolimus.
Synonymous polymorphism in the ABCB1 (MDR1) transporter gene influencing substrate drug efflux and systemic drug exposure.
Synonymous exon 26 variant in ABCB1 linked to altered mRNA stability and variable response to multiple cardiovascular medications.
Synonymous variant (c.3435C>T) in ABCB1 linked to altered P-glycoprotein expression and multi-drug transporter pharmacokinetics.
Coding missense variant (p.Ala893Ser/Thr) in P-glycoprotein multidrug resistance transporter affecting drug clearance and substrate transport.